2022

1. Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase-2 inhibitor and toceranib phosphate

   Veterinary and Comparative Oncology, Vol. 20, Núm. 1, pp. 179-188

2. Survival of dogs with pituitary-dependent hyperadrenocorticism treated twice daily with low doses of trilostane

   Veterinary Record, Vol. 191, Núm. 3, pp. no